Search

Search Constraints

You searched for: Author/Creator Algaba, A

Search Results

1. DOP19 Urinary metabolome in newly diagnosed treatment-naïve Crohn's Disease patients: Results from the IBDomics study. (27th May 2021)

2. P276 Influence of vedolizumab on extraintestinal manifestations in Inflammatory Bowel Disease: a nationwide multicenter study of the GETECCU Eneida registry. (27th May 2021)

3. P397 Effectiveness of vedolizumab (VDZ) for the induction of remission in inflammatory bowel disease (IBD): Results from the Spanish Eneida Registry. (16th January 2018)

4. P443 Clinical features, therapeutic requirements, and evolution of patients with Crohn's disease and upper digestive tract involvement (CROHNEX study). (25th January 2019)

5. P625 Characteristics of SARS-CoV-2 infection in IBD patients in the second and third wave compared with the first wave and with the data of general population. (27th May 2021)

6. P631 Treatment of established post-operative recurrence of Crohn's disease with anti-TNF agents: Preliminary data of a multicentre, nationwide study. (16th January 2018)

8. P816 Functional rare variants influence the clinical response to anti-TNF therapy in Crohn's disease. (25th January 2019)

9. Prevalence and Factors Associated With Fatigue in Patients With Inflammatory Bowel Disease: A Multicentre Study. (5th February 2019)